MedTrace Logo

ERAS Program Items Adherence, PROMs and RIOT After Colorectal Surgery

NCT04397627 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2020-05-22

No results posted yet for this study

Summary

Prospective multicenter observational no-profit study evaluating the impact of ERAS program items adherence rates on patient-reported outcomes (PRO) and return to intendend oncologic therapy (RIOT) after colorectal resection.

Prospective enrollment from November 2020 to October 2021 in 60 Italian surgical centers. All patients undergoing elective colorectal surgery with anastomosis will be included in a prospective database after written informed consent. A total of 3,000 patients is expected based on a mean of 50 cases per center.

Conditions

  • Colorectal Surgery
  • Enhanced Recovery After Surgery
  • Patient Reported Outcomes

Interventions

PROCEDURE

Colorectal resection

All patients undergoing elective colorectal surgery with anastomosis will be included in a prospective database after written informed consent.

Sponsors & Collaborators

  • Ospedale C & G Mazzoni

    lead OTHER

Principal Investigators

  • Marco Catarci, MD, FACS · Ospedale CG Mazzoni Ascoli Piceno

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397627 on ClinicalTrials.gov